Non-anti-Galα1-3Gal antibody, mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation

Journal of the American College of Surgeons

Volumn 194, Issue 6, 2002, Pages 765-773

  Gonzalez Stawinski, Gonzalo V ^a   Daggett, Casey W ^a   Lau, Christine L ^a   Karoor, Sujatha ^c   Love, Stephanie D ^a   Logan, John S ^b   Gaca, Jeffrey G ^a   Parker, William ^a   Davis Jr, Robert Duane ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Nextran   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENZYME ANTIBODY; GALACTOSE; GALACTOSYLGALACTOSE ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RITUXIMAB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; LUNG TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; LUNG DISEASES; LUNG TRANSPLANTATION; PAPIO; SWINE; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036285027     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01162-6     Document Type: Article

References (33)

1. Experimental renal heterotransplantation in widely divergent species
2. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients
3. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model
4. Characterization of porcine endothelial cell determinants recognized by human natural antibodies
5. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans
6. Human natural anti-α-galactosyl IgG: The specific recognition of α(1-3)-linked galactose residues
7. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans
8. Identification of porcine endothelial cell membrane antigens recognized by xenoreactive anitbodies
9. The role of anti-Galα13Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants
10. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
11. Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model
12. Total respiratory support from swine lungs in primate recipients
13. Transgenic swine lungs expressing human cd59 are protected from injury in a pig-to-human model of xenotransplantation
14. Ex vivo lung model of pig-to-human hyperacute xenograft rejection
15. Hyperacute lung rejection in a pig-to-human transplant model: The role of antipig antibody and complement
16. Human complement regulatory proteins protect swine lungs from xenogeneic injury
17. Leflunomide prolongs pulmonary allograft and xenograft survival
18. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and antiGal column immunoadsorption
19. Identification of antigens on porcine pulmonary microvascular endothelial cells recognized by human xenoreactive natural antibodies
20. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion
21. Immunoaffinity removal of xenoreactive antibodies using modified dialysis or microfiltration fibers
22. Complement-mediated pulmonary xenograft injury: Studies in swine-to-primate orthotopic single lung transplant models
23. An ELISA assay for xenoreactive natural antibodies
24. Absence of hyperacute rejection in pig-to-primate orrhotopic pulmonary xenografts
25. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage
26. Expression of human CD59 in transgenic pig organs engances organ survival in an ex vivo xenogeneic perfusion model
27. Life-supporting pig-toprimate renal xenotransplantation using genetically modified donors
28. Porcine platelet antigens recognized by human xenoreactive natural antibodies
29. The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants
30. Platelet activation induced by porcine factor VIII (Hyate:C)
31. Interaction of porcine von Willebrand factor with platelet glycoproteins lb and IIb/IIa complex
32. Further evidence that the residual vWF:Ag in porcine FVIII:C induces human platelet aggregation
33. Activation of human platelets by membrane-expressed A1 domain of von Willebrand factor